88
Participants
Start Date
July 31, 2012
Primary Completion Date
June 30, 2016
Study Completion Date
June 30, 2016
crizotinib
crizotinib 250 mg twice a day
crizotinib
crizotinib 250 mg once a day
crizotinib
crizotinib 250 mg twice a day
crizotinib
crizotinib 250 mg once a day
crizotinib
crizotinib 250 mg once a day
Emory University Hospital Midtown Laboratory, Atlanta
Emory University Hospital, Atlanta
Investigational Drug Service: The Emory Clinic Bldg A, Atlanta
The Emory Clinic, Atlanta
Winship Cancer Institute, Atlanta
University Hospital East, Columbus
Investigational Drug Services, Columbus
James Cancer Hospital, Columbus
The Ohio State University, Wexner Medical Center, Columbus
Martha Morehouse Medical Plaza, Columbus
Cancer Therapy & Research Center at UTHSCSA, San Antonio
Medical Arts and Research Center-MARC, San Antonio
Anschutz Cancer Pavilion, Room 2224, c/o Melinda Friesleben, Pharm D, Aurora
University of Colorado Denver - Clinical Translational Research Center, Aurora
University of Colorado Denver, Anschutz Cancer Pavilion, Aurora
University of Colorado Denver, Anschutz Inpatient Pavillion, Aurora
Keck Hospital of USC, Los Angeles
LAC&USC Medical Center, Los Angeles
USC/Norris Comprehensive Cancer Center / Investigational Drug Services, Los Angeles
USC/Norris Comprehensive Cancer Center, Los Angeles
Lead Sponsor
Pfizer
INDUSTRY